In conclusion, as reported in Fig. 8E, we found that TAE226 inhibitor of FAK combined with SOR slows down HCC growth by multifunctional epigenetic effects, which mainly include the reduction of FAK nuclear levels and its detrimental activity on histone H3 acetylation. This evidence concerns the gene PTK2 and hepatocellular carcinoma.